Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lisa A. Carey, MD
UNC Lineberger Comprehensive Cancer Center
Principal Investigator - William J. Irvin, MD
Bon Secours Virginia Health System / Bon Secours Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Moses Cone Regional Cancer Center at Wesley Long Community Hospital
Greensboro, North Carolina, United States
- Leo W. Jenkins Cancer Center at Ecu Medical School
Greenville, North Carolina, United States
- Rex Cancer Center at Rex Hospital
Raleigh, North Carolina, United States
- Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
Spartanburg, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jun 2008
- Primary completion
- 28 Sept 2010
- Completion
- 1 Jul 2011
- Last update posted
- 1 Aug 2017
- Registered enrollment
- 501
- Registry id
- NCT00764322
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.